Teladoc Health, Inc. - Common Stock (TDOC)

CUSIP: 87918A105

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
+1,944,814
Put/Call ratio
115%
SEC-reported price per share
$15.10
Number of holders
411
Value change
+$8,558,227
Number of buys
183
Open additional details 1 more signal available
Number of sells
206
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
182,000,940

Security key

87918A105

Report period

Q1 2024

Institutions

411

Top holders

10

Ownership snapshot

Top reported holders of TDOC - Teladoc Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ARK Investment Management...
Disclosed value leader
ARK Investment Management...
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F Highest disclosed value: $457,389,365 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ARK Investment Management LLC has the largest disclosed position value at $457.39M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARK Investment Management LLC's linked filing trail.
Disclosed position value Top 5
ARK Investment Management LLC $457.39M
VANGUARD GROUP INC $377.45M
BlackRock Finance, Inc. $283.2M
Sumitomo Mitsui Trust Group, Inc. $161.08M
Amova Asset Management Americas, ... $160.87M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ARK Investment Management LLC
13F
Company
13F
—
denominator unverified
$457,389,365
21,224,565 shares
— 31 Dec 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$377,450,987
17,515,127 shares
— 31 Dec 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$283,198,850
13,141,478 shares
— 31 Dec 2023
Sumitomo Mitsui Trust Group, Inc.
13F
Company
13F
—
denominator unverified
$161,079,225
7,474,674 shares
— 31 Dec 2023
Amova Asset Management Americas, Inc.
13F
Company
13F
—
denominator unverified
$160,868,035
7,464,874 shares
— 31 Dec 2023
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$116,189,777
5,391,637 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
411
Shares
129,813,184
Rows available
411
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
411
Q1 2024 holders
411
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .